Emmanuella Guenova
#137,918
Most Influential Person Now
Bulgarian dermatologist
Emmanuella Guenova's AcademicInfluence.com Rankings
Emmanuella Guenovaphilosophy Degrees
Philosophy
#7054
World Rank
#10207
Historical Rank
Logic
#4132
World Rank
#5387
Historical Rank
Download Badge
Philosophy
Why Is Emmanuella Guenova Influential?
(Suggest an Edit or Addition)Emmanuella Guenova's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection (1993) (1848)
- Differential T cell costimulatory requirements in CD28-deficient mice. (1993) (1456)
- Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. (1995) (943)
- Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4 (1991) (783)
- The influence of antigen organization on B cell responsiveness. (1993) (671)
- Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development (1993) (644)
- Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function (1997) (637)
- Normal B lymphocyte development but impaired T cell maturation in CD45-Exon6 protein tyrosine phosphatase-deficient mice (1993) (530)
- Antigen localisation regulates immune responses in a dose‐ and time‐dependent fashion: a geographical view of immune reactivity (1997) (529)
- Immune responses in interleukin-2-deficient mice. (1993) (503)
- Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. (2012) (481)
- Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth (2015) (470)
- CD8 is needed for development of cytotoxic T but not helper T cells (1991) (429)
- Duration of TCR stimulation determines costimulatory requirement of T cells. (1996) (425)
- Fibroblasts as efficient antigen-presenting cells in lymphoid organs. (1995) (329)
- Immunity in response to particulate antigen-delivery systems. (2005) (319)
- Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial (2008) (312)
- CD8 is needed for development of cytotoxic T cells but not helper T cells. (1991) (307)
- LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor (1996) (301)
- On the role of antigen in maintaining cytotoxic T-cell memory. (1996) (271)
- Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. (2012) (235)
- A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. (2002) (232)
- Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression (1991) (219)
- Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen (1992) (218)
- Human TH9 Cells Are Skin-Tropic and Have Autocrine and Paracrine Proinflammatory Capacity (2014) (192)
- Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems. (2010) (192)
- Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. (2009) (189)
- Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. (2006) (188)
- Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+ T-cell responses in melanoma patients (2012) (175)
- Mature T cell reactivity altered by peptide agonist that induces positive selection (1996) (174)
- Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression (2011) (172)
- Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells. (2005) (166)
- ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression (2011) (164)
- Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab. (2011) (155)
- Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? (1997) (155)
- Antigen kinetics determines immune reactivity (2008) (152)
- IL-4 abrogates TH17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells (2015) (147)
- Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study. (2012) (147)
- Intralymphatic immunization enhances DNA vaccination (2001) (145)
- The cGAS–STING pathway drives type I IFN immunopathology in COVID-19 (2022) (142)
- IL-12 protects from psoriasiform skin inflammation (2016) (141)
- TH2 Cytokines from Malignant Cells Suppress TH1 Responses and Enforce a Global TH2 Bias in Leukemic Cutaneous T-cell Lymphoma (2013) (141)
- Critical Role for Activation of Antigen-Presenting Cells in Priming of Cytotoxic T Cell Responses After Vaccination with Virus-Like Particles1 (2002) (140)
- Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells. (2014) (136)
- On immunological memory. (2000) (131)
- T cell responses are governed by avidity and co‐stimulatory thresholds (1996) (124)
- Natural Staphylococcus aureus‐derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals (2010) (120)
- Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients (2010) (120)
- Class II major histocompatibility complex‐restricted T cell function in CD4‐deficient mice (1994) (115)
- Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells. (2014) (114)
- A Virus-Like Particle-Based Vaccine Selectively Targeting Soluble TNF-α Protects from Arthritis without Inducing Reactivation of Latent Tuberculosis (2007) (109)
- Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL. (1991) (108)
- Direct intralymphatic injection of peptide vaccines enhances immunogenicity (2005) (104)
- Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells. (1994) (103)
- Adverse cutaneous drug eruptions: current understanding (2015) (103)
- The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients (2018) (103)
- Intralymphatic Injections as a New Administration Route for Allergen-Specific Immunotherapy (2009) (101)
- Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-help-independent B-cell responses (1993) (98)
- Induction of protective cytotoxic T cells with viral proteins (1994) (97)
- Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination. (1993) (97)
- T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs. (1993) (95)
- Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10. (2014) (95)
- Reduced thymic maturation but normal effector function of CD8+ T cells in CD8 beta gene-targeted mice (1994) (90)
- Mechanisms of allergen-specific desensitization. (2010) (89)
- Effector T‐Cell Induction and T‐Cell Memory versus Peripheral Deletion of T Cells (1993) (88)
- A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy. (2005) (87)
- Induction of unresponsiveness and impaired T cell expansion by staphylococcal enterotoxin B in CD28-deficient mice (1996) (86)
- Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients. (2018) (86)
- Virus-induced humoral immunity: on how B cell responses are initiated. (2013) (79)
- Component‐resolved in vitro diagnosis in carrot allergy: Does the use of recombinant carrot allergens improve the reliability of the diagnostic procedure? (2005) (78)
- How many specific B cells are needed to protect against a virus? (1994) (76)
- Allergen immunotherapy on the way to product-based evaluation—a WAO statement (2015) (76)
- Prevention of allergy by a recombinant multi‐allergen vaccine with reduced IgE binding and preserved T cell epitopes (2005) (75)
- Fucosyltransferase VII-Deficient Mice with Defective E-, P-, and L-Selectin Ligands Show Impaired CD4+ and CD8+ T Cell Migration into the Skin, but Normal Extravasation into Visceral Organs1 (2002) (74)
- Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials (2015) (71)
- Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation (1992) (69)
- Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration (2005) (67)
- PTPN2 Regulates Inflammasome Activation and Controls Onset of Intestinal Inflammation and Colon Cancer. (2018) (67)
- Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen‐induced septic shock (1996) (65)
- A Protective Allergy Vaccine Based on CpG- and Protamine-Containing PLGA Microparticles (2007) (65)
- Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly (2010) (64)
- Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis. (2008) (64)
- Intralymphatic Immunotherapy: Update and Unmet Needs (2018) (62)
- Epicutaneous allergen administration: is this the future of allergen‐specific immunotherapy? (2011) (61)
- Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant (2019) (60)
- Regulation of IgG antibody titers by the amount persisting of immune‐complexed antigen (1994) (60)
- Lympho-geographical concepts in vaccine delivery. (2010) (60)
- Pyoderma gangrenosum (2020) (58)
- Viral Particles Drive Rapid Differentiation of Memory B Cells into Secondary Plasma Cells Producing Increased Levels of Antibodies (2014) (58)
- T cell development in mice expressing splice variants of the protein tyrosine phosphatase CD45. (1997) (56)
- Vaccine against peanut allergy based on engineered Virus-Like-Particles displaying single major peanut allergens. (2019) (56)
- Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study (2019) (56)
- Relief from Zmp1-Mediated Arrest of Phagosome Maturation Is Associated with Facilitated Presentation and Enhanced Immunogenicity of Mycobacterial Antigens (2011) (54)
- Intralymphatic immunotherapy (2009) (54)
- Toll‐like receptor ligands as adjuvants in allergen‐specific immunotherapy (2005) (53)
- Prevention of autoimmune disease by retroviral-mediated gene therapy. (1995) (52)
- Design, engineering and in vitro evaluation of MHC class‐II targeting allergy vaccines (2007) (51)
- Antimicrobial Silk Clothing in the Treatment of Atopic Dermatitis Proves Comparable to Topical Corticosteroid Treatment (2006) (51)
- Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine (2014) (50)
- Treating insect‐bite hypersensitivity in horses with active vaccination against IL‐5 (2018) (50)
- Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome. (2015) (49)
- IL‐4‐mediated fine tuning of IL‐12p70 production by human DC (2008) (48)
- Peripheral T cells in mice lacking p56lck do not express significant antiviral effector functions. (1993) (47)
- Atopic eczema: genetics or environment? (2007) (46)
- Skin test to assess virus-specific cytotoxic T-cell activity. (1992) (44)
- Heat denaturation, a simple method to improve the immunotherapeutic potential of allergens (2005) (43)
- Intralymphatic immunotherapy: time interval between injections is essential. (2014) (42)
- Fewer protective cytotoxic T-cell epitopes than T-helper-cell epitopes on vesicular stomatitis virus (1993) (42)
- Is The Allergen Really Needed in Allergy Immunotherapy? (2014) (41)
- New routes for allergen immunotherapy (2012) (41)
- Analysis of anti‐tumour necrosis factor‐induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics (2018) (41)
- Alterations in the level of CD45 surface expression affect the outcome of thymic selection. (1997) (40)
- The use of anti‐T‐cell receptor‐Vβ antibodies for the estimation of treatment success and phenotypic characterization of clonal T‐cell populations in cutaneous T‐cell lymphomas (2002) (40)
- TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell-independent isotype switch in mice. (2013) (40)
- Low-affinity B cells transport viral particles from the lung to the spleen to initiate antibody responses (2012) (39)
- State‐of‐the‐art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI) (2019) (39)
- Epicutaneous Immunotherapy for Aeroallergen and Food Allergy (2013) (39)
- Intralymphatic immunotherapy: from the rationale to human applications. (2011) (39)
- Novel Delivery Routes for Allergy Immunotherapy: Intralymphatic, Epicutaneous, and Intradermal. (2016) (37)
- Nonimmunogenic tumor cells may efficiently restimulate tumor antigen-specific cytotoxic T cells. (1993) (37)
- Lentiviral Transduction of Dendritic Cells Confers Protective Antiviral Immunity In Vivo (2004) (37)
- Comparing safety of abrasion and tape-stripping as skin preparation in allergen-specific epicutaneous immunotherapy. (2014) (37)
- Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases (2018) (36)
- Active vaccination against interleukin‐5 as long‐term treatment for insect‐bite hypersensitivity in horses (2018) (35)
- Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study (2013) (35)
- Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective. (2021) (35)
- Intradermal photosensitisation facilitates stimulation of MHC class-I restricted CD8 T-cell responses of co-administered antigen. (2014) (35)
- Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling (2018) (34)
- Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets (2016) (34)
- Allergen‐specific immunotherapy: is it vaccination against toxins after all? (2017) (34)
- Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects. (2019) (34)
- PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma (2018) (33)
- Systemic corticosteroids for subcutaneous panniculitis‐like T‐cell lymphoma (2014) (33)
- In vivo versus in vitro assays for assessment of T- and B- cell function. (1994) (32)
- Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study (2017) (32)
- A VLP‐based vaccine against interleukin‐1α protects mice from atherosclerosis (2013) (32)
- A novel proangiogenic B cell subset is increased in cancer and chronic inflammation (2020) (32)
- Lymph Node–Targeted Immunotherapy Mediates Potent Immunity Resulting in Regression of Isolated or Metastatic Human Papillomavirus–Transformed Tumors (2009) (31)
- Photosensitisation facilitates cross-priming of adjuvant-free protein vaccines and stimulation of tumour-suppressing CD8 T cells. (2015) (31)
- Allergen immunotherapy in allergic rhinitis: current use and future trends (2017) (31)
- Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial. (2017) (29)
- Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study * (2020) (29)
- Novel therapies for cutaneous T-cell lymphoma: what does the future hold? (2014) (29)
- European dermatology forum – updated guidelines on the use of extracorporeal photopheresis 2020 – part 1 (2020) (29)
- Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides. (2009) (29)
- Novel administration routes for allergen-specific immunotherapy: a review of intralymphatic and epicutaneous allergen-specific immunotherapy. (2011) (29)
- PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer (2017) (28)
- Interleukin 31 in insect bite hypersensitivity—Alleviating clinical symptoms by active vaccination against itch (2019) (28)
- Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020 (2020) (28)
- Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma. (2013) (27)
- Targeting the MHC II presentation pathway in allergy vaccine development. (2007) (27)
- Classic Mediterranean Kaposi's sarcoma regression with sirolimus treatment. (2008) (27)
- Hidradenoma Papilliferum: A Clinicopathologic Study of 264 Tumors From 261 Patients, With Emphasis on Mammary-Type Alterations (2016) (27)
- BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced (2021) (27)
- Histiocytosis – cutaneous manifestations of hematopoietic neoplasm and non‐neoplastic histiocytic proliferations (2018) (27)
- Depth and Patterns of Adnexal Involvement in Primary Extramammary (Anogenital) Paget Disease: A Study of 178 Lesions From 146 Patients (2016) (26)
- Human CD4-major histocompatibility complex class II (DQw6) transgenic mice in an endogenous CD4/CD8-deficient background: reconstitution of phenotype and human-restricted function (1994) (25)
- Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma (2017) (25)
- Mapping of specific sentinel node locations for skin cancer of the head. (2011) (24)
- IgG4 but no IgG1 antibody production after intralymphatic immunotherapy with recombinant MAT‐Feld1 in human (2016) (24)
- Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs (2014) (24)
- Lupus profundus/panniculitis. (1997) (24)
- Interstitial granulomatous dermatitis with arthritis responding to tocilizumab. (2012) (24)
- Diagnostic relevance of direct immunofluorescence in ocular mucous membrane pemphigoid (2015) (24)
- Primary Localization and Tumor Thickness as Prognostic Factors of Survival in Patients with Mucosal Melanoma (2014) (23)
- Modular antigen-translocation as a novel vaccine strategy for allergen-specific immunotherapy (2009) (23)
- Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients. (2009) (23)
- ALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune Reactions (2019) (22)
- Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice. (2012) (22)
- Photochemical Internalization: Light Paves Way for New Cancer Chemotherapies and Vaccines (2020) (22)
- Risk Assessment of Hymenoptera Re-Sting Frequency: Implications for Decision-Making in Venom Immunotherapy (2012) (22)
- Photochemical targeting of antigens to the cytosol for stimulation of MHC class-I-restricted T-cell responses. (2013) (22)
- A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2 (2021) (22)
- Comparison of the sensitivity of in vivo and in vitro assays for detection of antiviral cytotoxic T cell activity. (1993) (21)
- Functional differences between protamine preparations for the transfection of mRNA (2020) (20)
- Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation (2020) (20)
- Recent advances in primary cutaneous T-cell lymphoma (2015) (20)
- Comparison of Microneedles and Adhesive-Tape Stripping in Skin Preparation for Epicutaneous Allergen Delivery (2015) (20)
- Efficacy and safety of oral alitretinoin in severe oral lichen planus – results of a prospective pilot study (2016) (20)
- Induction or Exacerbation of Psoriasis in Patients with Crohn's Disease under Treatment with Anti-TNF Antibodies (2014) (20)
- Functional differences between protamine preparations for the transfection of mRNA (2020) (20)
- Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis. (2013) (20)
- Comparison of pyoderma gangrenosum and Martorell hypertensive ischaemic leg ulcer in a Swiss cohort (2018) (19)
- TLR4 as a negative regulator of keratinocyte proliferation (2017) (19)
- Epidemiology of Dermatophytoses in Switzerland According to a Survey of Dermatophytes Isolated in Lausanne between 2001 and 2018 (2020) (19)
- Expression of CD164 on Malignant T cells in Sézary Syndrome. (2016) (19)
- Proteomic identification of a marker signature for MAPKi resistance in melanoma (2019) (18)
- Photosensitizer and Light Pave the Way for Cytosolic Targeting and Generation of Cytosolic CD8 T Cells Using PLGA Vaccine Particles (2015) (18)
- Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand. (2003) (18)
- Primary Cutaneous Lymphoma: Recommendations for Clinical Trial Design and Staging Update from the ISCL, USCLC, and EORTC. (2021) (18)
- European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 – Part 2 (2020) (18)
- Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab (2018) (17)
- Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndrome (2019) (17)
- Toxic epidermal necrolysis (2016) (17)
- Distinct T helper cell dependence of memory B‐cell proliferation versus plasma cell differentiation (2017) (16)
- Immunotherapy concepts under investigation (2011) (15)
- Carbonic anhydrase IX is associated with early pulmonary spreading of primary colorectal carcinoma and tobacco smoking. (2014) (15)
- Nodular malignant melanoma and multiple cutaneous neoplasms under immunosuppression with azathioprine. (2009) (15)
- Critical role for DNA vaccination frequency in induction of antigen-specific cytotoxic responses. (2006) (15)
- Efficacy and Safety of Allergen-Specific Immunotherapy in Rhinitis, Rhinoconjunctivitis, and Bee/Wasp Venom Allergies (2005) (15)
- Intralymphatic immunotherapy. (2009) (15)
- Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression. (2001) (14)
- Clemastine causes immune suppression through inhibition of extracellular signal-regulated kinase-dependent proinflammatory cytokines. (2011) (14)
- Intralymphatic immunotherapy and vaccination in mice. (2014) (14)
- Multicentric Bowen disease in linear porokeratosis. (2007) (14)
- Absence of TNFRp55 influences virus-induced autoimmunity despite efficient lymphocytic infiltration. (1998) (14)
- The contact sensitizer diphenylcyclopropenone has adjuvant properties in mice and potential application in epicutaneous immunotherapy (2012) (14)
- Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study (2020) (13)
- The antihistamines clemastine and desloratadine inhibit STAT3 and c‐Myc activities and induce apoptosis in cutaneous T‐cell lymphoma cell lines (2013) (13)
- Cutaneous Corynebacterium Infection Presenting with Disseminated Skin Nodules and Ulceration (2017) (13)
- Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients (2017) (12)
- Immunization of Cats against Fel d 1 Results in Reduced Allergic Symptoms of Owners (2020) (12)
- Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study. (2018) (12)
- Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients (2017) (12)
- Oncolytic Virotherapy Mediated Anti-Tumor Response: A Single-Cell Perspective (2020) (12)
- Successful treatment of recalcitrant lymphomatoid papulosis in a child with PUVA-bath photochemotherapy. (2009) (12)
- Skin Test Reactivity to Hymenoptera Venom after Venom Immunotherapy Correlates Inversely with the IgG/IgE Ratio (2017) (12)
- A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control (2020) (12)
- Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA–IIA Mycosis Fungoides (2021) (12)
- Banana Leaves As an Alternative Wound Dressing (2013) (12)
- Protamine-Based Strategies for RNA Transfection (2021) (12)
- Tinea incognito hidden under apparently treatment-resistant pemphigus foliaceus. (2008) (11)
- [Dapsone in granulomatous rosacea]. (1997) (11)
- Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update (2019) (11)
- Parental anxiety and concern for children undergoing dermatological surgery (2014) (11)
- Safety Profile of a Virus-Like Particle-Based Vaccine Targeting Self-Protein Interleukin-5 in Horses (2020) (11)
- [Immunotherapy of allergic rhinitis without allergens? : new options for immunomodulation by vaccination with virus-like particles and CpG motifs]. (2013) (11)
- Artificial neural networks and pathologists recognize basal cell carcinomas based on different histological patterns (2020) (11)
- Allergen-specific immunotherapy: Regulatory T cells or allergen-specific IgG? (2010) (10)
- A Randomized, Double-Blind, Placebo-Controlled Study to Test the Efficacy of Topical 2-Hydroxypropyl-Beta-Cyclodextrin in the Prophylaxis of Recurrent Herpes Labialis (2013) (10)
- Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients (2020) (10)
- Evaluation of visual analog scales for the assessment of symptom severity in allergic rhinoconjunctivitis. (2007) (10)
- Monoclonal Antibodies in Dermatooncology—State of the Art and Future Perspectives (2019) (10)
- Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome (2016) (9)
- Photochemical internalization (PCI)-mediated activation of CD8 T cells involves antigen uptake and CCR7-mediated transport by migratory dendritic cells to draining lymph nodes. (2021) (9)
- The cGAS–STING pathway drives type I IFN immunopathology in COVID-19 (2022) (9)
- Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®) (2020) (9)
- Immunotherapeutic targeting of allergic disease. (2006) (9)
- Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study * (2021) (8)
- The Phytotherapeutic Fenugreek as Trigger of Toxic Epidermal Necrolysis (2015) (8)
- An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel (2016) (8)
- Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T‐cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop * (2022) (8)
- AN EIF4G-RECRUITING APTAMER INCREASES THE FUNCTIONALITY OF IN VITRO TRANSCRIBED MRNA (2018) (8)
- Interferon alfa‐2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement (2019) (8)
- Brentuximab as a Treatment for CD 30 + Mycosis Fungoides and Sézary Syndrome (2015) (8)
- Less can be more: the impact of chemotherapy on cutaneous T-cell lymphomas. (2013) (7)
- Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions (2021) (7)
- Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas. (1997) (7)
- Alagille Syndrome Associated with Myelinated Retinal Nerve Fibers (2009) (7)
- Apremilast in Treatment-Refractory Recurrent Aphthous Stomatitis. (2019) (7)
- Efficacy and safety of colchicine in inflammatory skin diseases: a retrospective, monocentric study in a large tertiary center (2019) (7)
- Microvascular Skin Manifestations Caused by COVID-19 (2021) (7)
- High levels of lung resident CD4+CD28null cells in COPD: implications of autoimmunity (2013) (7)
- Cutaneous manifestations of SARS-CoV-2: A 2-center, prospective, case-controlled study (2021) (6)
- Treatment of pyoderma gangrenosum with topical factor XIII. (2013) (6)
- Skin lesions in anti-Pm-Scl-70 positive systemic sclerosis-dermatomyositis overlap syndrome improve during local PUVA phototherapy. (2013) (6)
- Combined Photosensitization and Vaccination Enable CD8 T-Cell Immunity and Tumor Suppression Independent of CD4 T-Cell Help (2019) (6)
- Increased chlormethine induced DNA double stranded breaks in malignant T cells from mycosis fungoides skin lesions (2021) (6)
- A weakly supervised deep learning approach for label-free imaging flow-cytometry-based blood diagnostics (2021) (6)
- Long–Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T–Cell Lymphoma; Results From a Single Institution Analysis (2020) (6)
- Response of Treponema pallidum particle agglutination test titers to treatment of syphilis. (2013) (6)
- Expression of inflammatory cytokines in psoriatic nails (2017) (6)
- Nickel sensitisation in mice: a critical appraisal. (2010) (6)
- Gene Amplification of CYP51B: a New Mechanism of Resistance to Azole Compounds in Trichophyton indotineae (2022) (6)
- Incidental Finding of Lamellar Calcification of the Falx Cerebri Leading to the Diagnosis of Gorlin-Goltz Syndrome (2013) (6)
- The Course of Mycosis Fungoides under Cytokine Pathway Blockers: A Multicentre Analysis of Real-life Clinical Data (2020) (6)
- Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROCLIPI international Study. (2020) (5)
- Parenteral Vaccine Administration: Tried and True (2015) (5)
- Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome) (2017) (5)
- The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region) (2022) (5)
- MFS1, a Pleiotropic Transporter in Dermatophytes That Plays a Key Role in Their Intrinsic Resistance to Chloramphenicol and Fluconazole (2021) (5)
- Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity * (2021) (5)
- Palmar-plantar erythrodysesthesia secondary to sunitinib treatment resulting in necrotic foot syndrome aggravated by background diabetic vascular disease. (2008) (5)
- A Cutaneous Allergen Neutralisation Test That Correlates with the Duration of Venom Immunotherapy (2006) (5)
- Adverse Reactions of Antibody-Therapy for Primary Cutaneous Lymphomas: Rituximab, Brentuximab Vedotin, Alemtuzumab, and Mogamulizumab. (2018) (5)
- T-cell-independent antiviral B cell responses in CD45-deficient mice. (1997) (5)
- Pseudolymphomatous Reaction to Red Tattoo Pigment (2018) (4)
- Interleukin 31 and targeted vaccination in a case series of six horses with chronic pruritus (2020) (4)
- IL-12 regulates type 3 immunity through interfollicular keratinocytes in psoriasiform inflammation (2021) (4)
- Disseminated Primary Cutaneous CD8+ Small/Medium-sized Pleomorphic T-cell Lymphoma Responding to Hydroxychloroquine. (2015) (4)
- Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans (2022) (4)
- Kinetics and persistence of anti‐SARS‐CoV‐2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort (2021) (4)
- Dapsone in a Large Tertiary Center: Outdated Therapeutic Option or Timeless Agent? (2019) (4)
- Treatment of recurrent aphthous stomatitis with fumaric acid esters. (2011) (4)
- Banana leaves: an alternative wound dressing material? (2013) (4)
- Inpatient Treatment for Severe Nonsurgical Dermatological Disorders: Prevalence, Care Infrastructure and Reimbursement in Switzerland (2015) (4)
- Visceral Organs into the Skin , but Normal Extravasation into T Cell Migration + and CD 8 + Impaired CD 4 ShowDefective E-, P-, and L-Selectin Ligands Fucosyltransferase VII-Deficient Mice with and (2002) (4)
- Infundibulocystic Structures and Prominent Squamous Metaplasia in Sebaceoma—A Rare Feature. A Clinicopathologic Study of 10 Cases (2016) (4)
- [Allergen specific immunotherapy for rhinitis allergica : New applications]. (2015) (3)
- Hypersensitivity reactions to non-steroidal anti-inflammatory drugs: results of an Austrian cohort study (2020) (3)
- Vasculitic leg ulcers in a patient with mixed myelodysplastic and myeloproliferative syndrome (2007) (3)
- When tuberous sclerosis complex becomes an emergency. (2009) (3)
- Individualized treatment approaches for Langerhans cell histiocytosis (2018) (3)
- Sensitivity and specificity of T-cell receptor PCR BIOMED-2 clonality analysis for the diagnosis of cutaneous T-cell lymphoma (2020) (3)
- Uniparental Disomy of Chromosome 2 Unmasks New ITGA6 Recessive Mutation and Results in a Lethal Junctional Epidermolysis Bullosa in a Newborn (2019) (3)
- [Tuberous sclerosis: an interdisciplinary diagnosis]. (2007) (3)
- CME: Erythema nodosum (2017) (3)
- Intraperitoneal administration of aluminium‐based adjuvants produces severe transient systemic adverse events in mice (2018) (3)
- Selective inhibition of HDAC6 sensitizes cutaneous T-cell lymphoma to PI3K inhibitors (2020) (3)
- Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose – a single center experience (2022) (3)
- A tissue culture infectious dose-derived protocol for testing of SARS-CoV-2 neutralization of serum antibodies on adherent cells (2021) (3)
- Dosing intervals in intralymphatic immunotherapy (2016) (3)
- Ingenol mebutate for mycosis fungoides (2019) (3)
- Molecular mechanisms and treatment modalities in equine Culicoides hypersensitivity. (2021) (3)
- Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome (2021) (3)
- 542 Changes in blood involvement in Sezary syndrome positively correlate with skin severity but not in mycosis fungoides (2018) (3)
- mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma (2021) (3)
- mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma (2021) (3)
- [Urticaria - the most frequent dermatological disease]. (2010) (3)
- Multivalent paediatric allergy vaccines protect against allergic anaphylaxis in mice (2014) (3)
- [Methods for increasing the immunogenicity of vaccines]. (2000) (2)
- Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment. (2021) (2)
- Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study) (2020) (2)
- Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC‐CLTG/ISCL survey (2022) (2)
- Optimizing the Functionality of in vitro-Transcribed mRNA (2018) (2)
- Administration routes for the delivery of vaccines and immunotherapeutics (2013) (2)
- Letter to the Editor: Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II (2019) (2)
- Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma (2021) (2)
- Optimizing the Functionality of in vitro-Transcribed mRNA (2018) (2)
- Immunoglobulin E-Mediated Anaphylaxis to Sesame (2008) (2)
- Mutanome Engineered RNA Immunotherapy (MERIT). (2015) (2)
- Real-world study of the use of pegylated interferon alfa for treatment of primary cutaneous T-cell lymphomas: an EORTC CLTF study (2022) (2)
- Photochemically-Mediated Inflammation and Cross-Presentation of Mycobacterium bovis BCG Proteins Stimulates Strong CD4 and CD8 T-Cell Responses in Mice (2022) (2)
- A Protective Allergy Vaccine Based on CpG- and Protamine-Containing PLGA Microparticles (2007) (2)
- Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation (2022) (2)
- The A to I editing landscape in melanoma and its relation to clinical outcome (2022) (2)
- Distribution of Human Papillomavirus Genotypes in Condylomata Acuminata: An Austrian Cohort Study (2019) (2)
- Development of a recombinant vaccine based on virus-like particles for the treatment of peanut allergy (2018) (2)
- (Carpe)DIEM - dermatological indications for electron microscopy: Amyloid deposition. [corrected]. (2012) (1)
- Periphere T-Zell Lymphome (2018) (1)
- Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type (2022) (1)
- Safety and Satisfaction in High-Definition Power-Assisted Liposculpture in Men Under Local Anesthesia (2021) (1)
- Mycosis fungoides‐derived exosomes and their microRNA‐1246 cargo: a message from the skin (2021) (1)
- Quality of life in patients with mycosis fungoides and Sezary syndrome is significantly worse in female patients, Sézary syndrome and those with more extensive skin involvement (2018) (1)
- Residents' corner March 2012. (Carpe)DIEM--dermatological indications for electron microscopy: orf infection. (2012) (1)
- Vaccine Against Peanut Allergy Based On Engineered Virus-Like-Particles And Major Peanut Allergens (2020) (1)
- Cutaneous Oncology: From Research to Diagnosis and Management (2016) (1)
- Residents’ corner January 2012. Carpe DIEM – Dermatological Indications for Electron Microscopy : Ehlers Danlos Syndrome (2012) (1)
- Toxic epidermal necrolysis [version 1; referees: 3 approved] (2016) (1)
- Prognostic factors in mycosis fungoides: the PROCLIPI study (2019) (1)
- Granulomatous slack skin: clinical characteristics, prognosis and response to therapy. A study from the Cutaneous Lymphoma French Study Group (2022) (1)
- Images in clinical medicine. Diagnostic finding in the iris. (2009) (1)
- Beneficial effects on weight gain, hepatic steatosis and expression of lipogenic target genes in a murine obesity model after IL-1 type cytokine inactivation (2014) (1)
- Strain matters in mouse models of peanut-allergic anaphylaxis: Systemic IgE-dependent and Ara h 2-dominant sensitization in C3H mice. (2023) (1)
- Case 1-2012: a man with persistent ulcers on the hands. (2012) (1)
- Hypersensitivity reactions to non-steroidal antiinflammatory drugs: results of an Austrian cohort study (2020) (1)
- Identification of Dermatophyte and Non-Dermatophyte Agents in Onychomycosis by PCR and DNA Sequencing—A Retrospective Comparison of Diagnostic Tools (2022) (1)
- Programmed death ligand 2 expression plays a limited role in adenocarcinomas of the gastroesophageal junction after preoperative chemotherapy (2021) (1)
- Blocking TNF-α/Th17 pathway with monoclonal cytokine antibodies may aggravate the course of mycosis fungoides: a multicenter retrospective analysis of real-world clinical data (2019) (1)
- Proliferation of CD 30 T-Helper 2 Lymphoma Cells Can Be Inhibited by CD 30 Receptor Cross-Linking with Recombinant CD 30 Ligand 1 (2003) (1)
- Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicenter study (2019) (1)
- Major Allergen Content In Allergen Immunotherapy Products: The Limited Value of Numbers. (2022) (1)
- An update on health-related quality of life from the PROCLIPI study (2021) (1)
- Real life data on advanced cutaneous T cell lymphoma patients treated with brentuximab vedotin: results from a multicenter European EORTC study (2019) (1)
- Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT). (2021) (1)
- Dome-shaped Papules on the Left Flank: A Quiz. Cutaneous Rosai-Dorfman Disease (sinus histiocytosis with massive lymphadenopathy. (2017) (1)
- Dogmas, challenges, and promises in phase III allergen immunotherapy studies (2021) (1)
- PCI-based vaccination: a novel method for targeting of MHC class I antigen presentation and stimulation of antigen-specific cytotoxic T cells (2017) (0)
- Formalin Inactivation ofVesicular Stomatitis VirusImpairs T-Cell- butNotT-Help-Independent (1993) (0)
- [HIV-1 vaccination--is there hope?]. (2005) (0)
- Modulation allergic response. (2001) (0)
- Quality of life in allergic rhinitis patients treated with intralymphatic immunotherapy (ILIT): a 19-year follow-up (2022) (0)
- P250 BENEFICIAL EFFECTS ON WEIGHT GAIN, HEPATIC STEATOSIS AND EXPRESSION OF LIPOGENIC TARGET GENES IN A MURINE OBESITY MODEL AFTER IL-1 TYPE CYTOKINE INACTIVATION (2014) (0)
- Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in a mycosis fungoides patient with central nervous system involvement (2018) (0)
- Lipofection with Synthetic mRNA as a Simple Method for T-Cell Immunomonitoring (2021) (0)
- Novel Allergen Immunotherapy Routes (2016) (0)
- Antigen-targeted, synthetic vaccines for metastatic cancer (2011) (0)
- Response from Zinkernagel et al (1997) (0)
- 1028 Cathelicidin peptide LL37 complexed to dsRNA induces the release of interleukin-36γ from human primary keratinocytes (2023) (0)
- associated with facilitated presentation and enhanced (2011) (0)
- Beneficial Effects on Hepatic Steatosis in a Murine Obesity Model after IL-1 Type Cytokine Inactivation (2014) (0)
- ADJUVANTS IN ALLERGY : ELEVATING EFFICACY (2016) (0)
- Sarcoidosis - a multisystem disease. (2022) (0)
- An in vivo mouse lymphoma model for photopheresis (1998) (0)
- DOP089 PTPN2 controls intestinal inflammation and promotes colitis-associated tumour formation via control of inflammasome activation and IL-1alpha release. (2017) (0)
- Multivariate allergen‐specific analysis and profiling of serum antibodies from patients with peanut allergy (2022) (0)
- [Allergen specific immunotherapy: new approaches]. (2010) (0)
- Year : 2014 Intralymphatic immunotherapy and vaccination in mice (0)
- Front & Back Matter (2012) (0)
- Beneficial effects of IL-1 cytokine inactivation and the role of the serine/threonine kinase MK-2 in hepatic steatosis in a murine obesity model (2015) (0)
- P0943 : Beneficial effects of IL-1 cytokine inactivation and the role of the serine/threonine kinase MK-2 in hepatic steatosis in a murine obesity model (2015) (0)
- Coated textiles for skin infections (2011) (0)
- IMMUNOLOGY BY VIRUSES (1993) (0)
- Allergen immunotherapy: progress and future outlook. (2023) (0)
- Intralymphatic injections as a new prospective administration route for allergen-specific immunotherapy (2010) (0)
- Virus-Like Particles Cytotoxic T Cell Responses After Vaccination Antigen-Presenting Cells in Priming of Critical Role for Activation of Kündig (2002) (0)
- [Transcutaneous applications for vaccination and immunotherapy]. (2014) (0)
- Update on the development of EORTC/CLTF questionnaires to assess HRQOL in primary cutaneous T-cell and B-cell lymphomas: phase I (2022) (0)
- Autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement: follow-up (2021) (0)
- Aggressive rare T cell lymphomas with manifestation in the skin: A monocentric cross-sectional case study (2018) (0)
- Precision medicine approach in a rare case of autosomal recessive congenital ichthyosis (2022) (0)
- Formation, and Tumorigenicity CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma (2013) (0)
- International Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of CTCL outcomes during COVID-19 (2021) (0)
- Residents' corner September 2012. (Carpe)DIEM. Dermatological indications for electron microscopy: argyria. (2012) (0)
- Treatment of early-stage mycosis fungoides: Results from the PROCLIPI study (2018) (0)
- Treatment-refractory bullous pemphigoid in a patient with Sézary syndrome (2022) (0)
- Innate Immunity & Microbiology (2010) (0)
- Erratum to: Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs’ uveitis syndrome? (2014) (0)
- Intralymphatic immunization to induce CTL responses prolonged effectors (1998) (0)
- A Rational Approach to Immune Intervention (1997) (0)
- Mycosis fungoides and Sézary syndrome (2021) (0)
- Granulomatous slack skin: clinical retrospective study of 8 cases of the Cutaneous Lymphoma French Study Group. (2021) (0)
- Retrospective validation of prognostic markers and models in a cohort of 60 patients with lethal mycosis fungoides (2019) (0)
- Survey on Dermatophytes Isolated from Animals in Switzerland in the Context of the Prevention of Zoonotic Dermatophytosis (2023) (0)
- Acrokeratosis Paraneoplastica (Bazex Syndrome): A Case Report (2022) (0)
- Histiocytoid Sweet’s Syndrome in a patient with myelodysplastic syndrome with multilineage dysplasia (MDS-MLD), and monoclonal gammopathy of undetermined significance (MGUS) IgG kappa type (2022) (0)
- The assessment of immune-regulatory effects of extracorporeal photopheresis in leukemic cutaneous T cell lymphoma, graft-versus-host disease and lung transplant rejection (2018) (0)
- [Mycosis fungoides and Sézary syndrome : a systematic review]. (2022) (0)
- Upregulation of integrin-associated protein on tumor T cells in CTCL inhibits IL-12 and Th1 immunity (2018) (0)
- Mogamulizumab‐associated rash (MAR) mars its efficacy in the treatment of cutaneous lymphoma (2021) (0)
- Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA 2021, 7, 5 (2022) (0)
- Residents' corner July 2012. (Carpe)DIEM--Dermatological Indications for Electron Microscopy: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). (2012) (0)
- Immune Defence, Cell Mediated (2006) (0)
- Residents’ corner November 2012. CarpeDIEM--Dermatological indications for electron microscopy: disseminated epidermolytic acanthomas. (2012) (0)
- Upregulation of HLA I on tumor skin T lymphocytes as a tumor immune escape mechanism in CTCL (2019) (0)
- Residents’ editorial choice (2012) (0)
- Expression of programmed death-1 (PD-1) and its ligands in Sézary syndrome (2019) (0)
- Residents'corner May 2011. (2011) (0)
- Residents' corner November 2011. (Carpe)DIEM - dermatological indications for electron microscopy: Ehlers Danlos syndrome. (2011) (0)
- Immunophenotypic identification and characterization of CTCL tumor cells in blood using standardized flow cytometry: a European multicenter study (2022) (0)
- 020 Cytokine imbalance during targeted therapies for psoriasis and atopic dermatitis – the yin yang of Th17 and Th2 (2022) (0)
- Lymphomatoid papulosis in pediatric population: preliminary results of a multicenter retrospective cohort study (2022) (0)
- IL-4 mediated conditioning of human dendritic cell precursors to become IL-12p70 producing DC (2008) (0)
- 21. Mainzer Allergie-Workshop (2009) (0)
- 446 IL32β supports the HLA I expression on tumor skin T lymphocytes as a tumor immune escape mechanism in cutaneous T-cell lymphoma (2022) (0)
- Novel Delivery Routes for Allergy Immunotherapy (2021) (0)
- Exacerbation of mycosis fungoides masquerading as psoriasis under cytokine-pathway blockers (2022) (0)
- T-cell receptor clonality analysis with the Biomed-2 PCR as a diagnostic tool in cutaneous T-cell lymphomas (2018) (0)
- 1572 HLA I shields tumor lymphocytes from NK-cell-mediated elimination in the skin (2023) (0)
- Long-term disease control after stem cell transplantation in primary cutaneous T-cell lymphoma; a single-center analysis (2019) (0)
- Schlapbach Proinflammatory Capacity 9 Cells Are Skin-Tropic and Have Autocrine and ParacrineHHuman T (2014) (0)
- 483 PTCH1 inactivation is sufficient to cause basaloid follicular hamartoma in pediatric Nevoid basal cell carcinoma syndrome (2022) (0)
- 264 Increased chlormethine induced DNA double stranded breaks in malignant T cells from mycosis fungoides skin lesions (2021) (0)
- 1569 A specific inflammatory gene signature in pityriasis rubra pilaris identifies a pathogenic role for keratinocytes (2023) (0)
- Residents’ corner January 2011 (2011) (0)
- Hyper-IgE-Syndrom (2016) (0)
- Papuloerythroderma of Ofuji (PEO) successfully treated with acitretin (2022) (0)
- Residents' corner March 2011. (2011) (0)
- Residents'corner July 2011. (2011) (0)
- Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion. (2023) (0)
- CD30+ Transformed Mycosis Fungoides Associated with Sweet-like Dermatosis (2022) (0)
- Case 26. Extranodal NK/T-Cell lymphoma, extra-nasal type (2021) (0)
- 1032 HLA I shield tumor skin T lymphocytes from NK-cell-mediated elimination (2018) (0)
- Analysis of anti‐tumour necrosis factor‐induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics (2018) (0)
- Ustekinumab for pyoderma gangrenosum-reply. (2012) (0)
- Case 34. Primary cutaneous aggressive epidermotropic T-cell lymphoma (PC-AETCL) with an aberrant immune phenotype (2021) (0)
- Lymph node imaging in patch/plaque mycosis fungoides; enlarged LN are infrequent but lymphomatous nodal involvement may occur and upstage patients to advanced disease (2018) (0)
- 1003 Malignant T cells inhibit anti-cancer immunity in cutaneous T cell lymphoma (2018) (0)
- Expression of TIGIT, BTLA, LAG3, FCRL3 and CTLA-4 in Sézary Syndrome (2018) (0)
- CD38 Targeting Holds Potential for the Treatment of Aggressive Refractory Cutaneous T-Cell Lymphomas. (2023) (0)
- Molecular Characterization Using Oncoscan Chromosome Microarray in an International Cohort of 51 Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) (2021) (0)
- Treatment of early-phase mycosis fungoides: results from the Prospective Cutaneous Lymphoma International (PROCLIPI) study (2019) (0)
- HLA I shield tumor skin T lymphocytes from NK-cell-mediated elimination (2018) (0)
- Effect of extracorporeal photopheresis on antibody-dependent cellular cytotoxicity in patients with Sézary syndrome (2019) (0)
- Development of EORTC/CLTF questionnaire to assess HRQOL in primary cutaneous T-cell and B-cell lymphomas: phase I (2021) (0)
- Human Th9 cells: a novel skin homing T cell subset with potent autocrine and paracrine proinflammatory properties (2013) (0)
- Adult T-cell leukemia-lymphoma (ATLL) with initial cutaneous manifestation and lymphatic drainage (2022) (0)
- The next generation virus-like particle platform for the treatment of peanut allergy. (2023) (0)
- RNA with chemotherapeutic base analogues as a dual-functional anti-cancer drug (2022) (0)
- A bizarre attack on the freedom of scientific expression (2015) (0)
- Residents' corner September 2011. Residents' editorial choice. (2011) (0)
- Contents Vol. 141, 2006 (2006) (0)
- Case 25. EBV-associated extranodal NK/T-Cell lymphoma with γ/δ TCR expression presented as aphthous stomatitis (2021) (0)
- Papuloerythroderma of Ofuji successfully treated with oral retinoids (2021) (0)
- Residents' corner November 2011. Residents' editorial choice. (2011) (0)
- PTPN2 Controls Intestinal Inflammation and Promotes Colitis-Associated Tumour Formation via Control of Inflammasome Activation and IL-1α Release (2017) (0)
- Lipofection with Synthetic mRNA as a Simple Method for T-Cell Immunomonitoring (2021) (0)
- Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in leukemic cutaneous T-cell lymphoma patients (2021) (0)
- Phaeohyphomycosis caused by Phialophora americana in a dog. (2022) (0)
- [Tinea capitis: new insights into an old disease]. (2023) (0)
- Residents’ corner May 2012. Residents’ editorial choice (2012) (0)
- 086 Terbinafine-resistant dermatophytosis: an emerging global health threat (2022) (0)
- An overall response in skin is associated with improved HRQoL in patients with MF/SS enrolled in the PROCLIPI study (2019) (0)
- Case 1. Folliculotropic Mycosis Fungoides with Central Nervous System Involvement (2021) (0)
- Therapy of chronic urticaria and recurrent angioedema (2001) (0)
- 439 Cytometry and machine learning based approaches for diagnosis of malignant cells in Sézary syndrome (2022) (0)
- IL32β supports the HLA I expression on tumor skin T lymphocytes as a tumor immune escape mechanism in cutaneous T-cell lymphoma (2022) (0)
- from Arthritis without Inducing Reactivation Protects α Selectively Targeting Soluble TNF- A Virus-Like Particle-Based Vaccine (2013) (0)
- Clinical Reasoning: A 39-Year-Old Man With Asymmetric Distal Weakness and Loss of Sensitivity (2022) (0)
- Die Dermatitis herpetiformis Duhring (2015) (0)
- International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study (2022) (0)
- Residents' corner May 2012. (Carpe)DIEM - dermatological indications for electron microscopy: Herpesvirus infection. (2012) (0)
- Targeting of Th17-related cytokines in patients with Darier Disease (2023) (0)
- Case 36. Primary cutaneous aggressive epidermotropic T-cell lymphoma as a composite lymphoma with B-cell chronic lymphocytic leukemia (2021) (0)
- Mortality in mycosis fungoides: Evaluation of prognostic markers and models in 58 patients (2018) (0)
- Residents'corner July 2011. (2011) (0)
- Cutaneous T-cell lymphoma of mycosis fungoides type with CD30 positive transformation and sweet like neutrophilic dermatosis (2021) (0)
- Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion (2022) (0)
- 411 Keratinocytes drive a specific inflammatory gene signature in pityriasis rubra pilaris (2022) (0)
- PTCH1 inactivation is sufficient to cause basaloid follicular hamartoma in paediatric Nevoid basal cell carcinoma syndrome (2022) (0)
- Targeting Ara h 2 with human-derived monoclonal antibodies prevents peanut-induced anaphylaxis in mice. (2023) (0)
- Selective inhibition of HDAC6 sensitizes CTCL to PI3K inhibitors (2018) (0)
- A study of quality of life in people with mycosis fungoides and Sézary syndrome (2020) (0)
- [Therapy of chronic urticaria and recurrent Quincke edema]. (2001) (0)
- IgE mediated anaphylaxis to sesame (2007) (0)
- Adverse cutaneous drug eruptions: current understanding (2015) (0)
- Mass cytometry and machine learning delineate tumor-defining cells in Sézary syndrome to allow discrimination from benign erythroderma (2021) (0)
- 抗肿瘤坏死因子诱导的皮肤病变的分析揭示了辅助型T细胞1强活性以及一些显著的免疫学特性 (2018) (0)
- 814 Uniparental inheritance of junctional epidermolysis bullosa (JEB) through mutation of ITGA6 and trisomic rescue (2018) (0)
- Defining B2 involvement in Sezary syndrome results from the PROCLIPI study (2019) (0)
- Time-to-next-treatment and time-to-next-systemic treatment in patients included in the PROCLIPI registry (2021) (0)
- Residents' corner September 2011. (Carpe)DIEM - Birbeck granule in Langerhans cell histiocytosis. (2011) (0)
- Pillars Article: Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function. Science. 1997. 275: 540-543. (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Emmanuella Guenova?
Emmanuella Guenova is affiliated with the following schools:
